↓ Skip to main content

Trimodal therapy for stage III-N2 non-small-cell lung carcinoma: a single center retrospective analysis

Overview of attention for article published in BMC Cancer, August 2014
Altmetric Badge

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Trimodal therapy for stage III-N2 non-small-cell lung carcinoma: a single center retrospective analysis
Published in
BMC Cancer, August 2014
DOI 10.1186/1471-2407-14-572
Pubmed ID
Authors

Vasileios Askoxylakis, Judith Tanner, Jutta Kappes, Hans Hoffmann, Nils H Nicolay, Harald Rief, Juergen Debus, Michael Thomas, Marc Bischof

Abstract

Treatment of locally advanced non-small-cell lung cancer is based on a combined approach. To study the impact of trimodal therapy for stage III-N2 NSCLC a single centre retrospective evaluation focusing on survival and therapy-related toxicity was performed.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 17%
Student > Doctoral Student 4 17%
Researcher 4 17%
Professor > Associate Professor 2 9%
Student > Master 2 9%
Other 4 17%
Unknown 3 13%
Readers by discipline Count As %
Medicine and Dentistry 11 48%
Nursing and Health Professions 4 17%
Unspecified 1 4%
Biochemistry, Genetics and Molecular Biology 1 4%
Unknown 6 26%